Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 70858 CHARLOTTE, NC
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,347,617
-$5,412,691 QoQ
Shares Held
944,345
-18.8% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 215 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VRDN ranks #92 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in VRDN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,347,617 944,345
2026-03-31 $22,760,308 1,163,615
2025-12-31 $30,812,439 990,117
2025-09-30 $5,303,477 245,759
2025-06-30 $3,227,197 230,844
2025-03-31 $2,428,056 180,123
2024-12-31 $4,737,039 247,107
2024-09-30 $4,117,044 180,969
2024-06-30 $2,740,905 210,677
2024-03-31 $8,330,082 475,733
2023-12-31 $6,238,835 286,448
2023-09-30 $3,148,118 205,223
2023-06-30 $4,252,484 178,751
2023-03-31 $6,482,642 254,821
2022-12-31 $3,370,190 115,378
2022-09-30 $1,162,834 56,696
2022-06-30 $135,704 11,729
2022-03-31 $329,731 17,833
2021-12-31 $188,090 9,514
2021-09-30 $2,845 173
2021-03-31 $267 16